1. pH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems

   Broesder, A., Woerdenbag, H. J., Prins, G. H., Nguyen, D. N., Frijlink, H. W. & Hinrichs, W. L. J., Aug-2020, In : Drug Discovery Today. 25, 8, p. 1362-1373 12 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Potential implications of COVID-19 in non-alcoholic fatty liver disease

   Prins, G. H. & Olinga, P., 25-May-2020, In : Liver International. 1 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

3. Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis

   van Dijk, F., Hazelhoff, C. M., Post, E., Prins, G. G. H., Rombouts, K., Poelstra, K., Olinga, P. & Beljaars, L., Mar-2020, In : Pharmaceutics. 12, 3, 15 p., 278.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Studying Non-Alcoholic Fatty Liver Disease: Development of an Ex Vivo Model

   Prins, G., Luangmonkong, T., Weymaere, J., Suriguga, S., Oosterhuis, D., Schuppan, D., Mutsaers, H. & Olinga, P., Jul-2017, p. 19-20.

   Research output: Contribution to conference › Abstract › Academic

5. INDUCTION OF STEATOSIS IN HUMAN LIVER EX VIVO

   Prins, G. H., Jansen, Y. J. M., Oosterhuis, D., Olinga, P. & Gier, K., Oct-2019, In : Hepatology. 70, p. 1311A-1311A 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (10) »